BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 3038581)

  • 1. [Fundamental study on ataxic mice (wriggle mouse Sagami)].
    Matsui K; Mukoyama M; Adachi K; Ando K
    Jikken Dobutsu; 1987 Apr; 36(2):185-9. PubMed ID: 3038581
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Changes in movement and ataxic gait with development in genetically ataxic mice: a comparison with the level of cerebellar cyclic nucleotide].
    Matsui K; Kato N; Ando K
    Jikken Dobutsu; 1988 Jan; 37(1):1-6. PubMed ID: 3366183
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Taltirelin improves motor ataxia independently of monoamine levels in rolling mouse nagoya, a model of spinocerebellar atrophy.
    Nakamura T; Honda M; Kimura S; Tanabe M; Oda S; Ono H
    Biol Pharm Bull; 2005 Dec; 28(12):2244-7. PubMed ID: 16327158
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Concentrations of thyrotropin-releasing hormone in the brain of ataxic mice.
    Mitsuma T; Adachi K; Ando K
    J Neurol Sci; 1986 Sep; 75(2):135-9. PubMed ID: 3093641
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Behavioral effects of ceruletide in Wriggle Mouse Sagami--in comparison with in Rolling Mouse Nagoya].
    Matsui K; Mano Y; Ando K
    Jikken Dobutsu; 1989 Jan; 38(1):61-4. PubMed ID: 2714379
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pro-thyrotropin-releasing hormone concentrations in the brain of ataxic mice.
    Mitsuma T; Adachi K; Mukoyama M; Ando K
    J Neurol Sci; 1990 Sep; 98(2-3):163-7. PubMed ID: 2123001
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cerebellar nitric oxide synthase, cGMP and motor function in two lines of cerebellar mutant mice, Staggerer and Wriggle Mouse Sagami.
    Ikeda M; Matsui K; Ishihara Y; Morita I; Murota S; Yuasa T; Miyatake T
    Neurosci Lett; 1994 Feb; 168(1-2):65-8. PubMed ID: 7518067
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The pharmacological effect of thyrotropin-releasing hormone on ataxic mutant mice.
    Mano Y; Matsui K; Toyoshima E; Ando K
    Acta Neurol Scand; 1986 Apr; 73(4):352-8. PubMed ID: 3088901
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alterations in local cerebral glucose metabolism and endogenous thyrotropin-releasing hormone levels in rolling mouse Nagoya and effect of thyrotropin-releasing hormone tartrate.
    Nakayama T; Nagai Y
    Jpn J Pharmacol; 1996 Nov; 72(3):241-6. PubMed ID: 8957685
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Elevated immunoreactive-somatostatin levels in the brain of ataxic mutant mice].
    Matsui K; Kato N; Watanabe N; Ando K
    Jikken Dobutsu; 1988 Jul; 37(3):263-8. PubMed ID: 2901364
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Distribution and characterization of the TRH receptors in the CNS of ataxic mutant mouse.
    Yamaguchi T; Hayashi K; Murakami H; Maruyama S; Yamaguchi M
    Neurochem Res; 1984 Apr; 9(4):477-84. PubMed ID: 6087174
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The antiataxic mechanism of TRH in rolling mouse Nagoya: the effects of pretreatment with dopaminergic and cholinergic drugs].
    Matsui K; Ando K
    Jikken Dobutsu; 1984 Oct; 33(4):465-9. PubMed ID: 6440800
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-ataxic effects of TRH and its analogue, TA-0910, in Rolling mouse Nagoya by metabolic normalization of the ventral tegmental area.
    Kinoshita K; Watanabe Y; Asai H; Yamamura M; Matsuoka Y
    Br J Pharmacol; 1995 Dec; 116(8):3274-8. PubMed ID: 8719807
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Studies on thyrotropin releasing hormone in cerebellar ataxia mutant mouse brain.
    Fukuma N; Nihei N
    Life Sci; 1986 May; 38(18):1625-31. PubMed ID: 2871469
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [A morphological study on the brain in wriggle mouse Sagami, a new neurological mutant with dystonic disorders, with special reference to the abnormality of the cerebellum].
    Kokubun T
    Hokkaido Igaku Zasshi; 1991 May; 66(3):333-47. PubMed ID: 1885159
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of TA-0910, a novel orally active thyrotropin-releasing hormone analog, on the gait of ataxic animals.
    Kinoshita K; Fujitsuka T; Yamamura M; Matsuoka Y
    Eur J Pharmacol; 1995 Feb; 274(1-3):65-72. PubMed ID: 7768282
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Concentrations of catecholamines and indoleamines in the central nervous system of Wriggle mouse Sagami.
    Kumazawa T; Adachi K; Ando K
    Comp Biochem Physiol C Comp Pharmacol Toxicol; 1989; 93(1):167-9. PubMed ID: 2471606
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Studies on the behavioral pharmacology of TRH-T in cytosine arabinoside-induced ataxic mice: a comparison with genetically ataxic mice].
    Matsui K; Mano Y; Mukoyama M; Muramoto O; Toyoshima E; Ando K
    Jikken Dobutsu; 1983 Jan; 32(1):13-9. PubMed ID: 6406242
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Levels of somatostatin and cholecystokinin in the brain of ataxic mutant mice.
    Matsui K; Masui A; Kato N; Adachi K
    Life Sci; 1993; 53(4):333-40. PubMed ID: 8100981
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Central noradrenaline metabolism in cerebellar ataxic mice.
    Muramoto O; Ando K; Kanazawa I
    Brain Res; 1982 Apr; 237(2):387-95. PubMed ID: 6123371
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.